Rituximab as a maintenance treatment in patients with pemphigus vulgaris: When is the right time for discontinuation?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rituximab as a maintenance treatment in patients with pemphigus vulgaris: When is the right time for discontinuation?

Published:2023-11-02 Issue:2 Volume:23 Page:406-408
ISSN:1473-2130
Container-title:Journal of Cosmetic Dermatology
language:en
Short-container-title:J of Cosmetic Dermatology

Author:

Aryanian Zeinab¹²³,Balighi Kamran¹²,Emadi Seyed Naser¹²,Hatami Parvaneh¹^ORCID

Affiliation:

1. Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences Tehran Iran

2. Department of Dermatology, Razi Hospital Tehran University of Medical Sciences Tehran Iran

3. Department of Dermatology Babol University of Medical Sciences Babol Iran

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jocd.16030

Reference20 articles.

1. Multiple cycles of rituximab therapy for pemphigus: A group of patients with difficult‐ to‐treat disease or a consequence of late rituximab initiation?

2. Rituximab exhibits a better safety profile when used as a first line of treatment for pemphigus vulgaris: A retrospective study

3. Role of maintenance rituximab (rituxan) therapy in the treatment of follicular lymphoma;Fowler NH;Pharm Ther,2011

4. Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

5. Rituxan nanoconjugation prolongs drug/cell interaction and enables simultaneous depletion and enhanced Raman detection of lymphoma cells

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP